Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elan Corporation PLC's Subsidiary Sells Remaining Stake In Alkermes Plc


Thursday, 31 Jan 2013 04:29pm EST 

Elan Corporation PLC announced that, following the close of trading, Elan, through its wholly-owned subsidiary, Elan Science Three Limited, agreed to sell, on customary terms, all of its remaining 7,750,000 ordinary shares of Alkermes plc (Alkermes) through Jefferies & Company Inc. pursuant to Rule 144 under the U.S. Securities Act of 1933. The sale is expected to close on February 6, 2013. 

Related Company News

Company Quote

55.01
0.84 +1.55%
26 Nov 2014